Academia is increasingly realizing the medical and financial possibilities that building personalized medicine programs can bring. Case in point: The Perelman School of Medicine at the University of Pennsylvania this year has unveiled the Center for Personalized Diagnostics, a joint initiative from the school's department of Pathology and Laboratory medicine and the Abramson Cancer Center. The center's goal: to have experts in genomic analysis, bioinformatics and cancer genetics work with oncologists who design clinical trials and treat patients in order to test new drugs. The idea is that their work will enable patients to have personalized diagnostics and treatment, by identifying the specific cancer mutation they may have, and then spotting the best possible treatment. Release